Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Xencor Inc (NASDAQ:XNCR)

26.11
Delayed Data
As of Dec 02
 +1.41 / +5.71%
Today’s Change
9.89
Today|||52-Week Range
28.09
+78.59%
Year-to-Date
No recent news for Xencor Inc.

Today’s Trading

Previous close24.70
Today’s open24.65
Day’s range24.28 - 26.75
Volume693,633
Average volume (3 months)284,213
Market cap$1.2B
Dividend yield--
Data as of 3:59pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)+13.46%
Earnings growth (this year)+208.89%
Earnings growth (next 5 years)--
Revenue growth (last year)+191.62%
P/E ratio26.4
Price/Sales20.55
Price/Book6.52

Competitors

 Today’s
change
Today’s
% change
IPXLImpax Laboratories I...-0.10-0.73%
RGENRepligen Corp+0.14+0.45%
SUPNSupernus Pharmaceuti...+0.65+3.07%
PTLAPortola Pharmaceutic...+0.62+3.58%
Data as of 3:59pm ET, 12/02/2016

Financials

Next reporting dateMarch 22, 2017
EPS forecast (this quarter)-$0.32
Annual revenue (last year)$27.8M
Annual profit (last year)-$17.6M
Net profit margin-63.37%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Bassil I. Dahiyat
Vice President-Finance &
Investor Relations
John J. Kuch
Corporate headquarters
Monrovia, California

Forecasts


Search for Jobs